Johan Bjorkegren, MD, PhD
img_Johan Bjorkegren
CLINICAL PROFESSOR | Genetics and Genomic Sciences
Multi-Disciplinary Training Area
Genetics and Genomic Sciences [GGS]

MD, Karolinska University Hospital

PhD, Karolinska Institutet


Selected Publications

Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV. Won Jun Lee, Haoxiang Cheng, Bridget M. Whitney, Robin M. Nance, Sierra R. Britton, Kristina Jordahl, Sara Lindstrom, Stephanie A. Ruderman, Mari M. Kitahata, Michael S. Saag, Amanda L. Willig, Greer Burkholder, Joseph J. Eron, Jason C. Kovacic, Johan L.M. Björkegren, W. Christopher Mathews, Edward Cachay, Matthew J. Feinstein, Mathew Budoff, Peter W. Hunt, Richard D. Moore, Jeanne Keruly, Mary E. McCaul, Geetanjali Chander, Allison Webel, Kenneth H. Mayer, Joseph A. Delaney, Paul K. Crane, Claudia Martinez, Heidi M. Crane, Ke Hao, Inga Peter. International Journal of Cardiology

FHL5 Controls Vascular Disease-Associated Gene Programs in Smooth Muscle Cells. Doris Wong, Gaelle Auguste, Christian L. Lino Cardenas, Adam W. Turner, Yixuan Chen, Yipei Song, Lijiang Ma, R. Noah Perry, Redouane Aherrahrou, Maniselvan Kuppusamy, Chaojie Yang, Jose Verdezoto Mosquera, Collin J. Dube, Mohammad Daud Khan, Meredith Palmore, Jaspreet Kalra, Maryam Kavousi, Patricia A. Peyser, Ljubica Matic, Ulf Hedin, Ani Manichaikul, Swapnil K. Sonkusare, Mete Civelek, Jason C. Kovacic, Johan L.M. Bjorkegren, Rajeev Malhotra, Clint L. Miller. Circulation Research

Genetic Regulation of SMC Gene Expression and Splicing Predict Causal CAD Genes. Rédouane Aherrahrou, Dillon Lue, R. Noah Perry, Yonathan Tamrat Aberra, Mohammad Daud Khan, Joon Yuhl Soh, Tiit Örd, Prosanta Singha, Qianyi Yang, Huda Gilani, Ernest Diez Benavente, Doris Wong, Jameson Hinkle, Lijiang Ma, Gloria M. Sheynkman, Hester M. Den Ruijter, Clint L. Miller, Johan L.M. Björkegren, Minna U. Kaikkonen, Mete Civelek. Circulation Research

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Bjorkegren during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • Clinical Gene Networks AB


  • Karolinska Institutet

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Clinical Gene Networks AB

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • University of Tartu

Scientific Advisory Board:

  • Clinical Gene Networks AB

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.